Needham & Company LLC Reaffirms Hold Rating for Sage Therapeutics (NASDAQ:SAGE)
Needham & Company LLC reissued their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Friday,Benzinga reports. SAGE has been the topic of a number of other reports. Bank of America assumed coverage on shares of Sage Therapeutics in a research note on Tuesday, March 11th. […]
More Stories
Landman Season 3: News and Updates on Release Date and Trailer
Landman has gained popularity from its very first season. The season premiered on November 17, 2024, and continued for approximately...
A Dawn of Harmony: Envisioning True Peace Between the United States and Iran
By Stephen Zogopoulos, USNN World News January 17, 2026 – In the shadow of escalating protests across Iran and the...
Judge Restricts ICE Actions Against Protesters in Minnesota
By Kimberly Hayek A federal judge in Minnesota on Friday ruled that federal immigration agents can’t detain or use nonlethal...
Over Half of New Hires Land Jobs in a Month—With Tempered Expectations
By Panos Mourdoukoutas The labor market is becoming more efficient and flexible, with job seekers finding and accepting positions more...
Volodymyr Zelenskyy’s Net Worth: Assets, Salary, and Real Estate
Zelenskyy’s remark on the current situation of the abduction of Venezuela’s President and his wife has brought him to the...
Walz Responds to Reports of Federal Probe for Allegedly Obstructing Law Enforcement
By Jill McLaughlin Gov. Tim Walz called reports of a federal investigation into his recent public statements encouraging Minnesotans to...